Incyte (INCY) Shares Outstanding (Diluted Average) (2010 - 2026)

Incyte (INCY) reported Shares Outstanding (Diluted Average) of $206.8 million for Q1 2026, up 4.36% on a YoY basis from $198.2 million in Q1 2025, and up 3.05% quarter-over-quarter from $200.7 million in Q4 2025.

Incyte (INCY) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends

Incyte has reported Shares Outstanding (Diluted Average) for 17 years, with the latest figure at $206.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 4.36% year-over-year to $206.8 million; the trailing twelve-month figure through Mar 2026 stood at $206.8 million (up 4.36% YoY), and the FY2025 full-year result was $200.7 million, down 4.67% from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 stood at $206.8 million, up from $200.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $227.2 million in Q1 2024, with the low at $198.2 million in Q1 2025.
  • Historically, Shares Outstanding (Diluted Average) has averaged $216.1 million across 5 years, with a median of $223.0 million in 2022.
  • Annual changes were most pronounced in 2025 — Shares Outstanding (Diluted Average) dropped 12.77% — and 2026, when it climbed 4.36%.
  • Incyte's Shares Outstanding (Diluted Average) stood at $224.0 million in 2022, then advanced by 0.88% to $225.9 million in 2023, then retreated by 6.82% to $210.5 million in 2024, then dropped by 4.67% to $200.7 million in 2025, then increased by 3.05% to $206.8 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $206.8 million (Q1 2026), $200.7 million (Q4 2025), and $201.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 206.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 206.83 Mn
Dec 31, 2025 200.70 Mn
Sep 30, 2025 201.43 Mn
Jun 30, 2025 198.53 Mn
Mar 31, 2025 198.20 Mn
Dec 31, 2024 210.53 Mn
Sep 30, 2024 211.76 Mn
Jun 30, 2024 221.33 Mn
Mar 31, 2024 227.22 Mn
Dec 31, 2023 225.93 Mn
Sep 30, 2023 225.76 Mn
Jun 30, 2023 225.54 Mn
Mar 31, 2023 225.59 Mn
Dec 31, 2022 223.96 Mn
Sep 30, 2022 223.63 Mn
Jun 30, 2022 223.28 Mn
Mar 31, 2022 222.95 Mn
Dec 31, 2021 222.07 Mn
Sep 30, 2021 222.25 Mn
Jun 30, 2021 222.06 Mn